Here are four insights:
1. These drug increases are impacting both brand-name drugs and generics.
2. This price trend may be a consequence of drug research and development costs.
3. Others argue pharmaceutical companies are taking advantage of a “lack of bulk purchasing power.”
4. The Affordable Care Act is also not helping lowering drug prices.
More articles on quality & infection control:
Zika virus may be linked to eye damage in babies — 6 points
Zika virus impacts United Blood Services — 4 insights
Vascular surgery patients likely to quit smoking if offered personalized help from surgeons: 5 points
